Role of metformin in male oxidative stress infertility (MOSI): An in vitro experimental study

Nida Farooqui, Sher Khan, Nida Zahid, Syed Muhammad Nazim, Mohammad Tahir, Rehana Rehman

Research output: Contribution to journalArticlepeer-review

Abstract

The study aimed to determine the in-vitro effect of metformin on total antioxidant capacity (TAC) of seminal samples of infertile male subjects. It was conducted from January to June 2022 on forty-four seminal plasma samples collected from male infertile patients, age ranging from 18 to 55 years. All 44 semen samples were treated as three distinct groups: (i) a control group (ii) a study group subjected to oxidative stress (OS) induction and (iii) a test group exposed to OS induction and subsequent treatment with metformin. OS was introduced by using commercially available 100μM hydrogen peroxide (H2O2) and incubated for twenty-four hours at 37ºC. After that 1 ml of 100 mmol/l concentration of commercially available Metformin (PHR 1331, CAS: 461-58-5) was administered to test group samples for additional 24h at 37ºC. Low levels of TAC were observed after OS induction in comparison to the control group (p=0.01). In test samples (after treatment with Metformin), a positive correlation of TAC with sperm count, normal sperm morphology and sperm motility were observed however, results were not significant. The antioxidant effect of Metformin was shown to improve the antioxidant capacity of OS induced samples and their sperm parameters in seminal plasma of infertile male subjects.

Original languageEnglish
Pages (from-to)663-667
Number of pages5
JournalPakistan Journal of Pharmaceutical Sciences
Volume37
Issue number3
Publication statusPublished - 1 May 2024

Fingerprint

Dive into the research topics of 'Role of metformin in male oxidative stress infertility (MOSI): An in vitro experimental study'. Together they form a unique fingerprint.

Cite this